Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynec…

Overview of attention for article published in Gynecologic Oncology, September 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 9 X users

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 18,658 followers.

RT @dsmgyo: Treatment of #chemotherapy-naive stromal ovarian tumors. Randomized phase II trial of #paclitaxel & #carboplatin vs. #bleomyci…

#gyncsm https://t.co/ypYH39Drmx

RT @dsmgyo: Treatment of #chemotherapy-naive stromal ovarian tumors. Randomized phase II trial of #paclitaxel & #carboplatin vs. #bleomyci…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.